Callan JMB Inc. Receives Nasdaq Delisting Warning for Equity Deficiency

summarizeSummary

Callan JMB Inc. received a notice from Nasdaq for failing to meet the minimum $2.5 million stockholders' equity requirement, initiating a 45-day period to submit a compliance plan.

check_boxKey Events

• Nasdaq Non-Compliance Notice

  The company received a deficiency letter from Nasdaq on April 7, 2026, for non-compliance with Listing Rule 5550(b)(1).

• Equity Deficiency

  Callan JMB Inc. failed to maintain the required minimum of $2,500,000 in stockholders' equity for continued listing on The Nasdaq Capital Market.

• Compliance Plan Deadline

  The company has 45 calendar days, until May 22, 2026, to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension until October 4, 2026.

• No Immediate Delisting

  The notice does not have an immediate effect on the listing or trading of the company's common stock, which will continue to trade under 'CJMB'.

auto_awesomeAnalysis

Callan JMB Inc. has received a formal notice from Nasdaq regarding its non-compliance with the minimum $2.5 million stockholders' equity requirement. This is a critical development, especially following the company's recent 10-K filing which disclosed a significant net loss and substantial doubt about its ability to continue as a going concern. While the company has 45 days to submit a compliance plan and potentially an extension until October 2026, failure to regain compliance could lead to delisting, severely impacting liquidity and investor confidence. This notice compounds the existing financial distress signals.